Cures Act screening and enrollment of Medicaid providers and pharmacies
This document notifies Medicaid providers, pharmacies, MCOs, and members in Rhode Island about the Cures Act requirement that providers and pharmacies be screened and enrolled with the State Medicaid Agency and the operational consequence of claim denials for non-enrolled pharmacies effective July 1, 2023.
No material clinical or coverage changes in this revision.
Cures Act Compliance and Operational Effects
Compliance and point-of-sale denial guidance
Operational consequences and member guidance for providers and pharmacies that are not screened and enrolled with the State Medicaid Agency:
Compliance requirements
- Providers and pharmacies must be screened by and enrolled with the State Medicaid Agency by January 1, 2018 as required by the 21st Century Cures Act (114 P.L. 255) and 42 CFR 438.602(b).
Consequences of non-compliance
- Continued non-compliance will result in pharmacy claim denials at point of sale, effective July 1, 2023.
Member guidance when claims are rejected
- Members experiencing rejected claims at point of sale should be advised to go to a different pharmacy that is enrolled with State Medicaid.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.